Lifecore Biomedical Valuation
| LFCR Stock | 7.46 0.15 2.05% |
At this time, the firm appears to be fairly valued. Lifecore Biomedical secures a last-minute Real Value of USD7.6 per share. The latest price of the firm is USD7.46. Our model forecasts the value of Lifecore Biomedical from analyzing the firm fundamentals such as Return On Equity of 0.17, current valuation of 400.55 M, and Profit Margin of 0.05 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Lifecore Biomedical's valuation include:
Price Book 15.3467 | Enterprise Value 400.5 M | Enterprise Value Ebitda 11.7861 | Price Sales 2.0959 | Forward PE 8.673 |
Fairly Valued
Today
Please note that Lifecore Biomedical's price fluctuation is slightly risky at this time. Calculation of the real value of Lifecore Biomedical is based on 3 months time horizon. Increasing Lifecore Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Lifecore stock is determined by what a typical buyer is willing to pay for full or partial control of Lifecore Biomedical. Since Lifecore Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lifecore Stock. However, Lifecore Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.46 | Real 7.6 | Target 9.5 | Hype 7.99 | Naive 7.39 |
The intrinsic value of Lifecore Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Lifecore Biomedical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Lifecore Biomedical helps investors to forecast how Lifecore stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lifecore Biomedical more accurately as focusing exclusively on Lifecore Biomedical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Lifecore Biomedical's intrinsic value based on its ongoing forecasts of Lifecore Biomedical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Lifecore Biomedical's closest peers.
Lifecore Biomedical Cash |
|
Lifecore Valuation Trend
Lifecore Biomedical's real value is important for investors to make better decisions and a more accurate overall view of Lifecore Biomedical's financial worth over time. Using both Lifecore Biomedical's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Lifecore Biomedical Total Value Analysis
Lifecore Biomedical is now forecasted to have valuation of 400.55 M with market capitalization of 269.21 M, debt of 130.36 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Lifecore Biomedical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
400.55 M | 269.21 M | 130.36 M |
Lifecore Biomedical Investor Information
About 70.0% of the company shares are owned by institutional investors. The company had not issued any dividends in recent years. Based on the analysis of Lifecore Biomedical's profitability, liquidity, and operating efficiency, Lifecore Biomedical is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.0069 | 0.0728 |
|
|
Lifecore Biomedical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Lifecore Biomedical has an asset utilization ratio of 46.86 percent. This connotes that the Company is making USD0.47 for each dollar of assets. An increasing asset utilization means that Lifecore Biomedical is more efficient with each dollar of assets it utilizes for everyday operations.Lifecore Biomedical Ownership Allocation
Lifecore Biomedical maintains a total of 36.83 Million outstanding shares. Over half of Lifecore Biomedical's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Lifecore Biomedical Profitability Analysis
The company reported the previous year's revenue of 128.26 M. Net Income was 9.33 M with profit before overhead, payroll, taxes, and interest of 27.29 M.About Lifecore Biomedical Valuation
The stock valuation mechanism determines Lifecore Biomedical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Lifecore Biomedical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lifecore Biomedical. We calculate exposure to Lifecore Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Lifecore Biomedical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 41.9 M | 50.2 M | |
| Operating Profit Margin | 0.07 | 0.01 | |
| Net Loss | 0.09 | (0.01) | |
| Gross Profit Margin | 0.33 | 0.17 |
Lifecore Biomedical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Lifecore Biomedical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 36.7 M | |
| Forward Price Earnings | 8.673 |
Lifecore Biomedical Current Valuation Indicators
Lifecore Biomedical's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Lifecore Biomedical's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Lifecore Biomedical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Lifecore Biomedical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Lifecore Biomedical's worth.Additional Tools for Lifecore Stock Analysis
When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.